<DOC>
	<DOC>NCT01688076</DOC>
	<brief_summary>This cross-over design study will evaluate the onset of action, efficacy, and duration of botulinum toxin A treatment on forehead/glabellar rhytid complexes with and without subsequent muscle contraction.</brief_summary>
	<brief_title>Treatment of Forehead/Glabellar Rhytide Complex With Botulinum Toxin A Injection</brief_title>
	<detailed_description>In this cross-over design study, the investigators will evaluate whether active muscle contraction following Botox® injection of the forehead/glabellar rhytid complex will impact the onset of action, efficacy, and duration of Botox® treatment.</detailed_description>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>In good health Is 1865 years of age Has static and dynamic forehead/glabellar wrinkles Has decided to receive Botox® treatment for their forehead/glabellar wrinkles Has the willingness and ability to understand and provide informed consent and communicate with the investigator Is willing to return for followup visits Pregnant or lactating Has received the following treatments in the forehead or glabellar region: botulinum toxin injections in the past 6 months ablative laser procedure in the past 6 months radiofrequency device treatment in the past 6 months ultrasound device treatment in the past 6 months medium to deep chemical peel in the past 6 months temporary soft tissue augmentation material in the past year semipermanent soft tissue augmentation material in the past 2 years permanent soft tissue augmentation material Is planning to receive within the next year, any cosmetic procedure (such as any chemical peels, botulinum toxin injections, ablative or nonablative laser procedures, filler injections, radiofrequency procedures, dermabrasion, ultrasound and face lifting procedures) in the forehead or glabellar region. Is planning to use tretinoin or retinoic acid in the next year Has an active infection in the forehead or glabellar region (excluding mild acne) Is allergic to cow'smilk protein Is allergic to albumin Taking aminoglycoside Is currently using anticoagulation therapy Has a history of bleeding disorders Is unable to understand the protocol or to give informed consent Is unable to return for followup visits Has a mental illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>